BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35832042)

  • 1. A nanoparticle-based tour de force for enhancing immunogenic cell death elicited by photodynamic therapy.
    Kepp O; Kroemer G
    Oncoimmunology; 2022; 11(1):2098658. PubMed ID: 35832042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
    Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
    J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression.
    Mao C; Yeh S; Fu J; Porosnicu M; Thomas A; Kucera GL; Votanopoulos KI; Tian S; Ming X
    Sci Transl Med; 2022 Jun; 14(648):eabh1261. PubMed ID: 35675434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Activatable Near-Infrared Afterglow Theranostic Prodrug with Self-Sustainable Magnification Effect of Immunogenic Cell Death.
    Gao Z; Jia S; Ou H; Hong Y; Shan K; Kong X; Wang Z; Feng G; Ding D
    Angew Chem Int Ed Engl; 2022 Oct; 61(40):e202209793. PubMed ID: 35916871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox-Activated Porphyrin-Based Liposome Remote-Loaded with Indoleamine 2,3-Dioxygenase (IDO) Inhibitor for Synergistic Photoimmunotherapy through Induction of Immunogenic Cell Death and Blockage of IDO Pathway.
    Liu D; Chen B; Mo Y; Wang Z; Qi T; Zhang Q; Wang Y
    Nano Lett; 2019 Oct; 19(10):6964-6976. PubMed ID: 31518149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death.
    Bao X; Xie L
    J Exp Clin Cancer Res; 2022 Jul; 41(1):222. PubMed ID: 35836249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxygen-boosted immunogenic photodynamic therapy with gold nanocages@manganese dioxide to inhibit tumor growth and metastases.
    Liang R; Liu L; He H; Chen Z; Han Z; Luo Z; Wu Z; Zheng M; Ma Y; Cai L
    Biomaterials; 2018 Sep; 177():149-160. PubMed ID: 29890364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart Nanovesicle-Mediated Immunogenic Cell Death through Tumor Microenvironment Modulation for Effective Photodynamic Immunotherapy.
    Yang W; Zhang F; Deng H; Lin L; Wang S; Kang F; Yu G; Lau J; Tian R; Zhang M; Wang Z; He L; Ma Y; Niu G; Hu S; Chen X
    ACS Nano; 2020 Jan; 14(1):620-631. PubMed ID: 31877023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanomaterials-Based Photodynamic Therapy with Combined Treatment Improves Antitumor Efficacy Through Boosting Immunogenic Cell Death.
    Jin F; Liu D; Xu X; Ji J; Du Y
    Int J Nanomedicine; 2021; 16():4693-4712. PubMed ID: 34267518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Light-Enhanced O
    Wang T; Zhang H; Han Y; Liu H; Ren F; Zeng J; Sun Q; Li Z; Gao M
    ACS Appl Mater Interfaces; 2019 May; 11(18):16367-16379. PubMed ID: 30994323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging photodynamic nanotherapeutics for inducing immunogenic cell death and potentiating cancer immunotherapy.
    Zhang S; Wang J; Kong Z; Sun X; He Z; Sun B; Luo C; Sun J
    Biomaterials; 2022 Mar; 282():121433. PubMed ID: 35202933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-cell-biomimetic Upconversion nanoparticles combining chemo-photodynamic therapy and CD73 blockade for metastatic triple-negative breast cancer.
    Jin F; Qi J; Liu D; You Y; Shu G; Du Y; Wang J; Xu X; Ying X; Ji J; Du Y
    J Control Release; 2021 Sep; 337():90-104. PubMed ID: 34274385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light triggered release of a triple action porphyrin-cisplatin conjugate evokes stronger immunogenic cell death for chemotherapy, photodynamic therapy and cancer immunotherapy.
    Song H; Cai Z; Li J; Xiao H; Qi R; Zheng M
    J Nanobiotechnology; 2022 Jul; 20(1):329. PubMed ID: 35842642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib.
    Sun X; Cao Z; Mao K; Wu C; Chen H; Wang J; Wang X; Cong X; Li Y; Meng X; Yang X; Yang YG; Sun T
    Biomaterials; 2020 May; 240():119845. PubMed ID: 32085974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ZnO-based multifunctional nanocomposites to inhibit progression and metastasis of melanoma by eliciting antitumor immunity via immunogenic cell death.
    Zhang Y; Guo C; Liu L; Xu J; Jiang H; Li D; Lan J; Li J; Yang J; Tu Q; Sun X; Alamgir M; Chen X; Shen G; Zhu J; Tao J
    Theranostics; 2020; 10(24):11197-11214. PubMed ID: 33042278
    [No Abstract]   [Full Text] [Related]  

  • 16. Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer.
    He H; Liu L; Liang R; Zhou H; Pan H; Zhang S; Cai L
    Acta Biomater; 2020 Mar; 104():188-197. PubMed ID: 31945508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of immunogenic cell death in murine colon cancer cells by ferrocene-containing redox phospholipid polymers.
    Kaneko M; Yamaguchi A; Ito A
    Cancer Sci; 2022 Oct; 113(10):3558-3565. PubMed ID: 35950374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser/GSH-Activatable Oxaliplatin/Phthalocyanine-Based Coordination Polymer Nanoparticles Combining Chemophotodynamic Therapy to Improve Cancer Immunotherapy.
    Huang Z; Chen Y; Zhang J; Li W; Shi M; Qiao M; Zhao X; Hu H; Chen D
    ACS Appl Mater Interfaces; 2021 Aug; 13(33):39934-39948. PubMed ID: 34396771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROS-induced autophagy in cancer cells assists in evasion from determinants of immunogenic cell death.
    Garg AD; Dudek AM; Ferreira GB; Verfaillie T; Vandenabeele P; Krysko DV; Mathieu C; Agostinis P
    Autophagy; 2013 Sep; 9(9):1292-307. PubMed ID: 23800749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCl Nanoparticles as Potential Inducer of Immunogenic Cell Death for Cancer Immunotherapy.
    Huang Z; Zhang X; Luo Y; Wang Y; Zhou S
    ACS Appl Bio Mater; 2023 Jun; 6(6):2404-2414. PubMed ID: 37192493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.